The highest level of scientific evidence supports cost-effectiveness of homeopathy – a finding that is unchanged by a recent paper by Leemhuis & Seifert
31 Mai 2024We read with interest a new paper by Leemhuis & Seifert published in March 2024, titled, “Prescriptions of homeopathic remedies at the expense of the German statutory health insurance from 1985 to 2021: scientific, legal and pharmacoeconomic analysis”. However, regrettably, this study fails to meet basic scientific standards for a meaningful economic evaluation and, as such, adds nothing of value to the evidence base on this topic. More